Rhenman--Partners-Asset-Management-Ab

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
94
Total Value
869997756
Accession Number
0001213900-25-042939
Form Type
13F-HR
Manager Name
Rhenman--Partners-Asset-Management-Ab
Data Enrichment
98% identified
92 identified2 unidentified

Holdings

94 positions • $870.0M total value
Manager:
Search and click to pin securities to the top
Page 5 of 5
GERON CORP
Shares:783.0K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$870.0M)
ICON PLC
Shares:7.0K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$870.0M)
Structure Therapeutics Inc.
Shares:70.0K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$870.0M)
Relay Therapeutics, Inc.
Shares:460.0K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$870.0M)
Xenon Pharmaceuticals Inc.
Shares:35.0K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$870.0M)
Medpace Holdings, Inc.
Shares:3.8K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$870.0M)
Annexon, Inc.
Shares:460.0K
Value:$887.8K
% of Portfolio:0.1% ($887.8K/$870.0M)
Immunocore Holdings plc
Shares:28.3K
Value:$839.0K
% of Portfolio:0.1% ($839.0K/$870.0M)
Avantor, Inc.
Shares:47.8K
Value:$775.3K
% of Portfolio:0.1% ($775.3K/$870.0M)
IDEAYA Biosciences, Inc.
Shares:39.5K
Value:$647.0K
% of Portfolio:0.1% ($647.0K/$870.0M)
Apellis Pharmaceuticals, Inc.
Shares:28.3K
Value:$617.8K
% of Portfolio:0.1% ($617.8K/$870.0M)
Penumbra Inc
Shares:2.2K
Value:$588.3K
% of Portfolio:0.1% ($588.3K/$870.0M)
REPLIGEN CORP
Shares:4.5K
Value:$572.6K
% of Portfolio:0.1% ($572.6K/$870.0M)
Immunovant, Inc.
Shares:25.9K
Value:$443.0K
% of Portfolio:0.1% ($443.0K/$870.0M)